A Retrospective Study of Fertility Counseling and Preservation Rates for Women of Reproductive Age With Breast Care After Integrating a Fertility Specialist Into a Multidisciplinary Tumor Board.

IF 2.9 3区医学 Q2 ONCOLOGY Clinical breast cancer Pub Date : 2024-09-05 DOI:10.1016/j.clbc.2024.09.003

Monique Swain, Madison Miller, Cara Cannella, Samfee Doe, Lindsay Petersen, Jessica Bensenhaver

{"title":"A Retrospective Study of Fertility Counseling and Preservation Rates for Women of Reproductive Age With Breast Care After Integrating a Fertility Specialist Into a Multidisciplinary Tumor Board.","authors":"Monique Swain, Madison Miller, Cara Cannella, Samfee Doe, Lindsay Petersen, Jessica Bensenhaver","doi":"10.1016/j.clbc.2024.09.003","DOIUrl":null,"url":null,"abstract":"Introduction: Many breast centers have adopted multidisciplinary tumor boards to discuss and develop treatment plans for patients diagnosed with breast cancer. This study aims to determine whether adding a fertility specialist to tumor board will improve fertility counseling and utilization in breast cancer patients METHODS: A retrospective study of reproductive age patients diagnosed with breast cancer between January 1, 2012, and January 31, 2020, before and after integrating a designated fertility specialist into a comprehensive multidisciplinary care (cMDC) tumor board. Rates of fertility counseling and preservation were assessed for patients treated before (pre-cMDC) and after (post-cMDC) tumor board enhancement. Associations of race/ethnicity, age, chemotherapy, hormone receptor status, insurance type, parity, stage, site of treatment, and home county with fertility care rates were assessed in the post-cMDC group.Results: Of 306 patients diagnosed with breast cancer, 117 (38%) were in the pre-cMDC and 189 (62%) were in the post-cMDC tumor board group. Significantly more patients in the post-cMDC tumor board group were offered fertility counseling than patients in the pre-cMDC tumor board group (23.3% (44) vs. 0.9% (1); P < .001). However, rate of fertility preservation did not differ significantly between groups.Conclusion: Integrating a fertility specialist within a cMDC tumor board may help improve rates of fertility counseling among breast cancer patients but may not improve preservation rates.","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clbc.2024.09.003","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Many breast centers have adopted multidisciplinary tumor boards to discuss and develop treatment plans for patients diagnosed with breast cancer. This study aims to determine whether adding a fertility specialist to tumor board will improve fertility counseling and utilization in breast cancer patients METHODS: A retrospective study of reproductive age patients diagnosed with breast cancer between January 1, 2012, and January 31, 2020, before and after integrating a designated fertility specialist into a comprehensive multidisciplinary care (cMDC) tumor board. Rates of fertility counseling and preservation were assessed for patients treated before (pre-cMDC) and after (post-cMDC) tumor board enhancement. Associations of race/ethnicity, age, chemotherapy, hormone receptor status, insurance type, parity, stage, site of treatment, and home county with fertility care rates were assessed in the post-cMDC group.

Results: Of 306 patients diagnosed with breast cancer, 117 (38%) were in the pre-cMDC and 189 (62%) were in the post-cMDC tumor board group. Significantly more patients in the post-cMDC tumor board group were offered fertility counseling than patients in the pre-cMDC tumor board group (23.3% (44) vs. 0.9% (1); P < .001). However, rate of fertility preservation did not differ significantly between groups.

Conclusion: Integrating a fertility specialist within a cMDC tumor board may help improve rates of fertility counseling among breast cancer patients but may not improve preservation rates.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

一项关于将生育专家纳入多学科肿瘤委员会后，乳腺癌育龄妇女生育咨询和保胎率的回顾性研究。

导言：许多乳腺中心已采用多学科肿瘤委员会来讨论和制定乳腺癌患者的治疗方案。本研究旨在确定在肿瘤委员会中增加一名生育专家是否会改善乳腺癌患者的生育咨询和利用情况方法：对2012年1月1日至2020年1月31日期间诊断为乳腺癌的育龄患者进行回顾性研究，研究对象为将指定的生育专家纳入综合多学科治疗（cMDC）肿瘤委员会前后的患者。对肿瘤委员会加强前（cMDC 前）和加强后（cMDC 后）接受治疗的患者的生育咨询率和生育保护率进行了评估。评估了cMDC后组中种族/民族、年龄、化疗、激素受体状态、保险类型、奇偶数、分期、治疗部位和家乡县与生育关怀率的关系：在 306 名确诊为乳腺癌的患者中，有 117 人（38%）属于前肿瘤监测委员会组，189 人（62%）属于后肿瘤监测委员会组。获得生育咨询的肿瘤委员会会后组患者明显多于肿瘤委员会会前组患者（23.3% (44) vs. 0.9% (1)；P < .001）。然而，各组之间的生育力保存率并无明显差异：将生育专家纳入 cMDC 肿瘤委员会可能有助于提高乳腺癌患者的生育咨询率，但不一定能提高保留率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical breast cancer 医学-肿瘤学

CiteScore

5.40

自引率

3.20%

发文量

174

审稿时长

48 days

期刊介绍： Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.